Biotech Up Massively On Follow-Up Data

By: Tomas Ronolski - AllPennyStocks.com News

Wednesday, April 12, 2023

A Phoenix-based biotech company put on quite a show on Wednesday as shares experienced quite a bit of volatility on what appears to be the third-most actively traded day for the stock in the last year.

Shares of Creative Medical Technology Holdings Inc. (Nasdaq:CELZ) rallied strongly on Wednesday following the company announcing positive one-year follow-up data and significant efficacy using CELZ-001 to treat patients with Type 2 Diabetes without any serious adverse effects reported, according to the release.

Traders snatched up shares of this micro cap all the way up to $1.33/share (+174.79%) at the session high. This stock is known to experience some pretty significant whipsaws so be sure to keep an eye on this one!

Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid-derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.

Copyright © 2023 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.